Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Microtubules in Signaling01:22

Microtubules in Signaling

The primary cilium, made up of microtubules, acts as antennae on the cell surfaces for relaying external stimuli into the cells. These fine hair-like structures are present, generally one per cell. These are non-motile cilia in a 9+0 microtubules arrangement, where the central pair of microtubules are absent. The primary cilia arise from the basal body embedded in the cell membrane. Intraflagellar transport (IFT) carries requisite proteins from the cytoplasm to the cilium because the primary...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Nature immunology·2026
Same author

Revisiting X-linked agammaglobulinemia.

Journal of human immunity·2026
Same author

FDA approves gene therapy for Wiskott-Aldrich syndrome.

The Journal of allergy and clinical immunology·2026
Same author

Treatment of canine hemophilia A via intraosseous delivery of a platelet-specific factor VIII-lentiviral vector.

Blood vessels, thrombosis & hemostasis·2026
Same author

Extracellular vesicles as gatekeepers of antigen trafficking in DNA vaccination.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Clinical spectrum of Wiskott-Aldrich syndrome carriers: Self-reported survey of 193 carriers.

Clinical immunology (Orlando, Fla.)·2025

Related Experiment Video

Updated: Jul 9, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Wiskott-Aldrich syndrome.

Luigi D Notarangelo1, Carol H Miao, Hans D Ochs

  • 1Division of Immunology, Children's Hospital, Harvard Medical School, Boston, MA, USA.

Current Opinion in Hematology
|November 29, 2007
PubMed
Summary

Wiskott-Aldrich syndrome (WAS) arises from mutations in the WAS protein gene. Advances in understanding WAS protein function and gene therapy offer hope for curing this lethal genetic disorder.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Wiskott-Aldrich syndrome (WAS) is a rare genetic disorder caused by mutations in the Wiskott-Aldrich syndrome protein (WASp) gene.
  • WASp is a cytoplasmic protein crucial for immune cell function, motility, and protection against autoimmune diseases.

Purpose of the Study:

  • To review recent advancements in understanding the molecular basis of Wiskott-Aldrich syndrome.
  • To explore the implications of these findings for developing effective cures for WAS.

Main Methods:

  • Analysis of genotype-phenotype correlations in WAS patients.
  • Investigation of Wiskott-Aldrich syndrome protein functional domains.
  • Long-term follow-up of hematopoietic stem cell transplantation (HSCT) outcomes.

More Related Videos

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Jul 9, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
07:17

Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation

Published on: August 23, 2024

  • Studies utilizing Wiskott-Aldrich syndrome protein-deficient cell lines and knockout mouse models.
  • Main Results:

    • Identification of a spectrum of clinical phenotypes strongly correlated with specific gene mutations.
    • Elucidation of Wiskott-Aldrich syndrome protein's role in immune signaling and cell dynamics.
    • Refinement of hematopoietic stem cell transplantation protocols based on patient outcomes.
    • Development of preclinical models supporting gene therapy approaches.

    Conclusions:

    • WAS gene mutations lead to distinct clinical presentations, including classic WAS, X-linked thrombocytopenia, and intermittent forms.
    • Wiskott-Aldrich syndrome protein is vital for both innate and adaptive immunity, cell migration, and immune homeostasis.
    • Hematopoietic stem cell transplantation success is influenced by patient age, donor factors, and conditioning.
    • Gene therapy holds significant promise for curing Wiskott-Aldrich syndrome due to WASp's exclusive expression in hematopoietic stem cells.